MedMe Health joins the 2025 C100 Growth cohort
MedMe Health was selected for C100's 2025 Growth cohort, a program that gives Canadian AI and technology scale-ups mentorship, peer groups and access to a network of operators, executives and investors.
MedMe Health was selected for the 2025 cohort of the C100 Growth Program, which supports Canadian AI and technology scale-ups as they grow into global companies.
The program gives leadership teams customized mentorship, role-based peer groups, in-person workshops and access to a network of growth operators, executives, investors and service partners. C100 reports that companies in the 2025 cohort were, on average, on track to exceed $10M in annual revenue in 2025, with revenue growth between 100% and 500% year over year.
Meet the full 2025 C100 Growth cohort.
Ready to enhance your pharmacy's clinical practice?
See how MedMe turns clinical services into reliable, billable revenue across your stores.
Book a demo